Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gent

Showing results (171-180 of 242) with videos related to

Pageof 25
Sort By:
Blood|February 1, 1982
The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosisA Zielinsky, J Hirsh, G Straumanis, et al.
Annals of Internal Medicine|September 1, 1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind studyA G Turpie, M Gent, R Côte, et al.
The American Journal of Cardiology|November 26, 1993
Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-InvestigatorsS J Connolly, M Gent, R S Roberts, et al.
Neurology|October 26, 1999
Antiplatelet therapy: views from the expertsJ D Easton, H C Diener, N M Bornstein, et al.
The American Journal of Cardiology|August 15, 1993
Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study GroupA Haq, C D Morgan, R F Wilson, et al.
Transplantation Proceedings|June 1, 1988
Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 monthsJ Dupré, C R Stiller, M Gent, et al.
Circulation|April 1, 1983
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challengeR D Hull, C J Carter, R M Jay, et al.
Circulation|October 1, 1996
Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR StudyJ A Cairns, J Gill, B Morton, et al.
The New England Journal of Medicine|October 9, 1986
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgeryA G Turpie, M N Levine, J Hirsh, et al.
Lancet (London, England)|June 22, 1991
Cyclophosphamide and plasma exchange in multiple sclerosisJ H Noseworthy, M K Vandervoort, M Penman, et al.
Pageof 25

Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Blood|February 1, 1982
The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosisA Zielinsky, J Hirsh, G Straumanis, et al.
Annals of Internal Medicine|September 1, 1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind studyA G Turpie, M Gent, R Côte, et al.
The American Journal of Cardiology|November 26, 1993
Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-InvestigatorsS J Connolly, M Gent, R S Roberts, et al.
Neurology|October 26, 1999
Antiplatelet therapy: views from the expertsJ D Easton, H C Diener, N M Bornstein, et al.
The American Journal of Cardiology|August 15, 1993
Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study GroupA Haq, C D Morgan, R F Wilson, et al.
Transplantation Proceedings|June 1, 1988
Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 monthsJ Dupré, C R Stiller, M Gent, et al.
Circulation|April 1, 1983
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challengeR D Hull, C J Carter, R M Jay, et al.
Circulation|October 1, 1996
Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR StudyJ A Cairns, J Gill, B Morton, et al.
The New England Journal of Medicine|October 9, 1986
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgeryA G Turpie, M N Levine, J Hirsh, et al.
Lancet (London, England)|June 22, 1991
Cyclophosphamide and plasma exchange in multiple sclerosisJ H Noseworthy, M K Vandervoort, M Penman, et al.
Pageof 25